Fingerprint
Dive into the research topics of 'Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer
Allan Lipton, Laurence M. Demers, Harold A. Harvey, Kathleen B. Kambic, Howard Grossberg, Carolyn Brady, H. Adlercruetz, Patrick F. Trunet, Richard J. Santen
Research output: Contribution to journal › Article › peer-review
109
Scopus
citations